Lilly buys dairy hormone unit for $300M
Elanco, a division of Eli Lilly and Co., will spend $300 million and an undisclosed “contingent consideration” to buy all rights to a popular dairy cow hormone and its sales and manufacturing operations from St. Louis-based Monsanto Co. Elanco has been selling the supplement, called Posilac, outside the United States for a decade. Now Elanco […]